15Nov 2022
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta‐analysis

Systemic pharmacological treatments for chronic plaque psoriasis: a network meta‐analysis

Our review shows that, compared to placebo, the biologics infliximab, bimekizumab, ixekizumab, and risankizumab were the most effective treatments for achieving PASI 90 in people with moderate‐to‐severe psoriasis on the basis of high‐certainty evidence.

  • #dermatology

Like

Save

Share